Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The human red blood cell membrane is a composite biological membrane that envelops erythrocytes, consisting of a lipid bilayer supporting numerous embedded and peripheral proteins. It comprises three structural layers: the outer glycocalyx (rich in carbohydrates), the lipid bilayer (containing nearly equal masses of cholesterol and phospholipids with asymmetric distribution across leaflets), and the cytoskeletal protein network (predominantly spectrin, actin, ankyrin, protein 4.1, band 3, among others)[2][1][5][4]. These features confer unique mechanical properties, such as exceptional deformability and durability, critical for red cell survival in circulation[1][2][5]. The membrane proteins serve diverse functions—including ion transport, structural support, and cell-cell recognition—while its loss of integrity or alteration underlies various hereditary hemolytic anemias and can mediate susceptibility to blood-borne pathogens or immunological attack[3][5][4]. While not a therapeutic target as a whole, it contains many proteins that are disease-associated or have pharmacological relevance. In summary: \"Human red blood cell membrane\" is not a canonical therapeutic target or molecule, but a highly specialized composite structure essential to red cell function, containing many distinct molecular targets and disease roles, and must be subdivided for meaningful pharmacological analysis[2][1][5][3][4].
Not applicable to the membrane as a whole; for membrane proteins, mechanisms include inhibition of ion transport, alteration of cytoskeletal interactions, blocking of pathogen entry, etc.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Human red blood cell membrane (RBC membrane).